ClinicalTrials.gg
CompletedNCT04531085Updated Sep 19, 2024

Treatment of Medial Epicondyle Fractures in Children and Adolescents

An interventional study of Operative treatment and Long arm cast in Medial Epicondyle Fracture of the Humerus, 7 To16 Year Old Children and Adolecents and More Than 2 Mm of Displacement, sponsored by Helsinki University Central Hospital. Completed at 4 sites in Finland. Open to participants aged 7 Years to 16 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Helsinki University Central Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Aug 2019, registered Aug 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
7 Years to 16 Years
Sex
All
01

Study summary

Cast immobilization in situ versus open reduction and internal fixation of displaced medial epicondyle fractures in children between 7 and 16 years old. A non-inferiority randomized controlled trial.

Read the detailed description

This is a multicenter, controlled, prospective, randomized non-inferiority study comparing operative treatment to non-operative treatment of over 3 mm dislocated pediatric medial epicondyle fractures without joint incarceration or ulnar nerve dysfunction. A total of 120 patients will be randomized in 1:1 ratio to either operative or non-operative treatment. The study will have a parallel non-randomized patient preference arm. Non-operative treatment will be upper limb immobilization with long arm cast for 4 weeks. Operative treatment will be open reduction and internal fixation (ORIF). Data is collected at baseline and at each follow-up up to 2 years. Quick-DASH is used as primary outcome measure. Secondary outcomes are patient reported pain, differences in range of motion, PedsQL Life inventory questionnaire as well as Mayo elbow preformance score.

02

Conditions studied

  • Medial Epicondyle Fracture of the Humerus
  • 7 To16 Year Old Children and Adolecents
  • More Than 2 Mm of Displacement
03

In context

Lead sponsor

Helsinki University Central Hospital is the lead sponsor of 311 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Over 2 mm displaced medial epicondyle fracture of humerus on primary AP or lateral X-ray

Exclusion criteria

Exclusion Criteria:

  • Ulnar nerve dysfunction
  • Pathological fracture
  • Open fracture
  • Systemic bone disease
  • Concomitant fracture or injury of the same upper limb requiring operative intervention
  • Other disease preventing participation in full follow-up regime or range of motion exercises
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • Active comparator
    RCT operative

    Procedure of preference is open reduction and internal fixation (ORIF) with cannulated non-resolvable 4.0mm screw with or without washer. If the fracture fragment is too small or fragmented for screw fixation 1.6mm - 1.8mm Kirshner-wires and/or bone anchor are used. Long arm cast for 4 weeks.

    Procedure: Operative treatment

  • Active comparator
    RCT Non-operative

    Non-operative treatment means upper limb immobilization with forearm in neutral pro-supination with a long arm cast for 4 weeks.

    Procedure: Long arm cast

  • Other
    Patient preference operative

    Procedure of preference is open reduction and internal fixation (ORIF) with cannulated non-resolvable 4.0mm screw with or without washer. If the fracture fragment is too small or fragmented for screw fixation 1.6mm - 1.8mm Kirshner-wires and/or bone anchor are used. Long arm cast for 4 weeks.

    Procedure: Operative treatment

  • Other
    Patient preference non-operative

    Non-operative treatment means upper limb immobilization with forearm in neutral pro-supination with a long arm cast for 4 weeks.

    Procedure: Long arm cast

Interventions

  • ProcedureOperative treatment

    Surgery

  • ProcedureLong arm cast

    cast immobilization

06

What researchers measure

Primary outcomes

  1. Quick Disabilities of the Arm, Shoulder and Hand score questionnaire(QuickDASH)

    Minimum value is 0 and maximum 100. Higher value indicates worse function. Statistically significant difference in QuickDASH score is 6.8 (18) at 12 months FU.

    Time frame: 12 months

Secondary outcomes

  1. Range of Motion (ROM) degrees difference of the elbow as compared to uninjured arm

    Difference in active ROM in comparison to uninjured arm. Maximum value is 160 degrees minimum 0. Lower value indicates better outcome.

    Time frame: 12 months

  2. Measurement Model for the Pediatric Quality of Life Inventory questionnaire (PedsQL)

    Minimum score is 0 and maximum 100. Higher score indicates better health related quality of life.

    Time frame: 12 months

  3. Measurement Model for the Pediatric Quality of Life Inventory Pediatric Pain Questionaire (PEDS QL PPQ)

    Minimum score 0 maximum 10. Higher value indicates higher pain intensity.

    Time frame: 12 months

  4. Cosmetic Visual Analoque Scale (CVAS)

    Minimum score 0 maximum 100. Higher value indicates better cosmetic appearance

    Time frame: 12 months

  5. Mayo Elbow Performance Score (MEPS)

    Minimum score 0 maximum 100. Higher value indicates better performance.

    Time frame: 12 months

  6. Need for additional procedures (number)

    Minimum value 0, no maximum value. Lower value indicates better outcome.

    Time frame: 12 months

  7. Grip strength (kg) with hand held dynamometer (jamar)

    compared to standard for age kg/age

    Time frame: 12 months

  8. Sensation and cold intolerance

    semmes-weinstein monofilaments scored as normal or abnormal

    Time frame: 12 months

07

Study locations

4 sites
  • HUS New Childrens Hospital
    Helsinki, 00029HUS, Finland
  • Kuopio University Hospital
    Kuopio, Finland
  • Oulu University Hospital
    Oulu, Finland
  • Turku University Hospital
    Turku, Finland
08

References and documents

Publications

  • Grahn P, Helenius I, Hamalainen T, Kivisaari R, Nietosvaara Y, Sinikumpu JJ, Jalkanen J, Loyttyniemi E, Ahonen M; Finnish Pediatric Orthopedic Study Group Investigators. Casting vs Surgical Treatment of Children With Medial Epicondyle Fractures: A Randomized Clinical Trial. JAMA Netw Open. 2025 May 1;8(5):e258479. doi: 10.1001/jamanetworkopen.2025.8479. PubMed 40327343 ↗
  • Hamalainen T, Ahonen M, Helenius I, Jalkanen J, Lastikka M, Nietosvaara Y, Salonen A, Sinikumpu JJ, Grahn P. Cast immobilisation in situ versus open reduction and internal fixation of displaced medial epicondyle fractures in children between 7 and 16 years old. A study protocol for a randomised controlled trial. BMJ Open. 2021 May 3;11(5):e044627. doi: 10.1136/bmjopen-2020-044627. PubMed 33941629 ↗

Individual participant data

Plan to share: Yes — Data will be available upon request. Any requests should be sent to the principal investigator.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: upon request. Most of the above published in BMJ Open.

Access criteria: Please see BMJ open

Data sharing details ↗ · bmjopen.bmj.com

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2019 to primary completion in Aug 2024, 60 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2020
First posted
Aug 28, 2020
StartActual
Aug 30, 2019
Primary completionActual
Aug 30, 2024
CompletionActual
Aug 30, 2024
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04531085
Responsible party
Petra Grahn (Hand Surgeon, Helsinki University Central Hospital) — Principal investigator
First posted
Aug 28, 2020
Start date
Aug 30, 2019
Primary completion
Aug 30, 2024
Completion
Aug 30, 2024
Last update
Sep 19, 2024

Study contacts

Petra Grahn, MD
principal investigator · Helsinki University Hospital, New Childrens Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion